| Ajay Virmani, MD | |
|
650 Cedar Creek Grade Ste 100, Winchester, VA 22601 | |
| (540) 535-0000 | |
| (540) 535-0032 |
| Full Name | Ajay Virmani |
|---|---|
| Gender | Male |
| Speciality | Interventional Cardiology |
| Experience | 33 Years |
| Location | 650 Cedar Creek Grade Ste 100, Winchester, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1871559773 | NPI | - | NPPES |
| 3810013758 | Other | WV | MEDICAID GROUP |
| 11119653 | Other | MAMSI PROFESSIONAL | |
| 0087006000 | Medicaid | WV |
| Facility Name | Location | Facility Type |
|---|---|---|
| Berkeley Medical Center | Martinsburg, WV | Hospital |
| Jefferson Medical Center | Ranson, WV | Hospital |
| Winchester Medical Center | Winchester, VA | Hospital |
| War Memorial Hospital Inc | Berkeley springs, WV | Hospital |
| Potomac Valley Hospital | Keyser, WV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Potomac Valley Hospital Of Wva, Inc | 8123917788 | 40 |
| West Virginia University Medical Corporation | 1052224565 | 1613 |
| West Virginia University Medical Corporation | 1052224565 | 1613 |
News Archive
Writing in the January 3 issue of Cancer Cell, researchers at University of California San Diego School of Medicine report that detection of "copy editing" by a stem cell enzyme called ADAR1, which is active in more than 20 tumor types, may provide a kind of molecular radar for early detection of malignancies and represent a new therapeutic target for preventing cancer cell resistance to chemotherapy and radiation.
Curis, Inc. a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that its collaborator Genentech, a member of the Roche Group, has initiated a Phase II clinical trial of GDC-0449, an orally-administered small molecule Hedgehog Pathway Inhibitor, as a single-agent therapy for patients with operable basal cell carcinoma (BCC).
More problems are being reported in external defibrillators, the life-saving medical devices located in emergency rooms, airports and other public places. These Automated external defibrillators, or AEDs are generally used in patients who have suffered sudden cardiac arrest if used in the first few minutes after their collapse. They deliver electrical energy to the heart to restore its normal rhythm.
By the time older adults are diagnosed with Alzheimer's disease, the brain damage is irreparable. For now, modern medicine is able to slow the progression of the disease but is incapable of reversing it. What if there was a way to detect if someone is on the path to Alzheimer's before substantial and non-reversible brain damage sets in?
› Verified 8 days ago
| Entity Name | West Virginia University Medical Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275504508 PECOS PAC ID: 1052224565 Enrollment ID: O20031111000207 |
News Archive
Writing in the January 3 issue of Cancer Cell, researchers at University of California San Diego School of Medicine report that detection of "copy editing" by a stem cell enzyme called ADAR1, which is active in more than 20 tumor types, may provide a kind of molecular radar for early detection of malignancies and represent a new therapeutic target for preventing cancer cell resistance to chemotherapy and radiation.
Curis, Inc. a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that its collaborator Genentech, a member of the Roche Group, has initiated a Phase II clinical trial of GDC-0449, an orally-administered small molecule Hedgehog Pathway Inhibitor, as a single-agent therapy for patients with operable basal cell carcinoma (BCC).
More problems are being reported in external defibrillators, the life-saving medical devices located in emergency rooms, airports and other public places. These Automated external defibrillators, or AEDs are generally used in patients who have suffered sudden cardiac arrest if used in the first few minutes after their collapse. They deliver electrical energy to the heart to restore its normal rhythm.
By the time older adults are diagnosed with Alzheimer's disease, the brain damage is irreparable. For now, modern medicine is able to slow the progression of the disease but is incapable of reversing it. What if there was a way to detect if someone is on the path to Alzheimer's before substantial and non-reversible brain damage sets in?
› Verified 8 days ago
| Entity Name | Potomac Valley Hospital Of Wva, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316054919 PECOS PAC ID: 8123917788 Enrollment ID: O20040311001344 |
News Archive
Writing in the January 3 issue of Cancer Cell, researchers at University of California San Diego School of Medicine report that detection of "copy editing" by a stem cell enzyme called ADAR1, which is active in more than 20 tumor types, may provide a kind of molecular radar for early detection of malignancies and represent a new therapeutic target for preventing cancer cell resistance to chemotherapy and radiation.
Curis, Inc. a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that its collaborator Genentech, a member of the Roche Group, has initiated a Phase II clinical trial of GDC-0449, an orally-administered small molecule Hedgehog Pathway Inhibitor, as a single-agent therapy for patients with operable basal cell carcinoma (BCC).
More problems are being reported in external defibrillators, the life-saving medical devices located in emergency rooms, airports and other public places. These Automated external defibrillators, or AEDs are generally used in patients who have suffered sudden cardiac arrest if used in the first few minutes after their collapse. They deliver electrical energy to the heart to restore its normal rhythm.
By the time older adults are diagnosed with Alzheimer's disease, the brain damage is irreparable. For now, modern medicine is able to slow the progression of the disease but is incapable of reversing it. What if there was a way to detect if someone is on the path to Alzheimer's before substantial and non-reversible brain damage sets in?
› Verified 8 days ago
| Entity Name | Potomac Valley Hospital Of Wva, Inc |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1912979873 PECOS PAC ID: 8123917788 Enrollment ID: O20061104000290 |
News Archive
Writing in the January 3 issue of Cancer Cell, researchers at University of California San Diego School of Medicine report that detection of "copy editing" by a stem cell enzyme called ADAR1, which is active in more than 20 tumor types, may provide a kind of molecular radar for early detection of malignancies and represent a new therapeutic target for preventing cancer cell resistance to chemotherapy and radiation.
Curis, Inc. a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that its collaborator Genentech, a member of the Roche Group, has initiated a Phase II clinical trial of GDC-0449, an orally-administered small molecule Hedgehog Pathway Inhibitor, as a single-agent therapy for patients with operable basal cell carcinoma (BCC).
More problems are being reported in external defibrillators, the life-saving medical devices located in emergency rooms, airports and other public places. These Automated external defibrillators, or AEDs are generally used in patients who have suffered sudden cardiac arrest if used in the first few minutes after their collapse. They deliver electrical energy to the heart to restore its normal rhythm.
By the time older adults are diagnosed with Alzheimer's disease, the brain damage is irreparable. For now, modern medicine is able to slow the progression of the disease but is incapable of reversing it. What if there was a way to detect if someone is on the path to Alzheimer's before substantial and non-reversible brain damage sets in?
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ajay Virmani, MD 650 Cedar Creek Grade Ste 100, Winchester, VA 22601-6453 Ph: (540) 535-0000 | Ajay Virmani, MD 650 Cedar Creek Grade Ste 100, Winchester, VA 22601 Ph: (540) 535-0000 |
News Archive
Writing in the January 3 issue of Cancer Cell, researchers at University of California San Diego School of Medicine report that detection of "copy editing" by a stem cell enzyme called ADAR1, which is active in more than 20 tumor types, may provide a kind of molecular radar for early detection of malignancies and represent a new therapeutic target for preventing cancer cell resistance to chemotherapy and radiation.
Curis, Inc. a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that its collaborator Genentech, a member of the Roche Group, has initiated a Phase II clinical trial of GDC-0449, an orally-administered small molecule Hedgehog Pathway Inhibitor, as a single-agent therapy for patients with operable basal cell carcinoma (BCC).
More problems are being reported in external defibrillators, the life-saving medical devices located in emergency rooms, airports and other public places. These Automated external defibrillators, or AEDs are generally used in patients who have suffered sudden cardiac arrest if used in the first few minutes after their collapse. They deliver electrical energy to the heart to restore its normal rhythm.
By the time older adults are diagnosed with Alzheimer's disease, the brain damage is irreparable. For now, modern medicine is able to slow the progression of the disease but is incapable of reversing it. What if there was a way to detect if someone is on the path to Alzheimer's before substantial and non-reversible brain damage sets in?
› Verified 8 days ago
Dr. Raveen Chawla, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1880 Amherst Street, Suite 100 And Suite 200, Winchester, VA 22601 Phone: 540-662-0306 Fax: 855-264-2066 | |
Dr. Neal S Gaither, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1880 Amherst Street, Suite 100 And Suite 200, Winchester, VA 22601 Phone: 540-662-0306 Fax: 855-264-2066 | |
Dr. Lee Resta, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 400 Campus Blvd Ste 100, Winchester, VA 22601 Phone: 540-662-1108 | |
Kristine Gade Reed, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 400 Campus Blvd., Suite 100, Winchester, VA 22601 Phone: 540-662-1108 Fax: 540-450-2244 | |
Dr. David Jack Lecronier, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 190 Campus Blvd Ste 201, Winchester, VA 22601 Phone: 540-536-5980 Fax: 540-536-5979 | |
T. Glen Bouder, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1840 Amherst St, Winchester, VA 22601 Phone: 540-536-8874 Fax: 540-536-7847 | |
Dr. Manish J Lakhani, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1880 Amherst Street, Suite 100 And Suite 200, Winchester, VA 22601 Phone: 540-662-0306 Fax: 855-264-2066 |